Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (11997)	12/2/1997 5:47:00 PM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

Andy, I was referring to an International trial. The Phase II/III trials for oral Targretin and Phase III for topical Targretin were announced well over a year ago and the North American sites have been listed at Centerwatch and the NCI for quite some time. Maybe with the new FDA reforms they can combine sites, but I was envisioning US trials (well underway) for sales in the US and the International trial for sales elsewhere (Europe and Australia).